ClinicalTrials.gg
CompletedNCT03356509Updated Sep 18, 2018

Effect of Exercise on Chocolate Addiction

An interventional study of Exercise in Acute Exercise and Addictive Behavior, sponsored by University of Miami. Completed at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-18.

Sponsored by University of Miami · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The study will use stress inducing tasks to determine if there are significant improvements in mood, chocolate cravings, and attentional bias to chocolate in overweight/obese chocolate abusers following rest and a bout of high intensity interval exercise.

Read the detailed description

The purpose of this research study is to investigate whether a single high intensity interval exercise (HIIE) bout, following two stress-inducing tasks, reduces addictive behavior to chocolate. Volunteers must complete the consent form before being able to participate in two days of testing (exercise day and control day) which will be presented in randomized order. The two days will be separated by a one to 7 day washout period. Subjects will be required to submit a three day chocolate diary then abstain from chocolate on the 4th day. They will also be asked to record everything they eat and drink on the day before and the morning of the study and list three types of chocolate they crave most. Two stress-inducing tasks will be performed on both days followed by completion of either 26 minutes of HIIE or seated resting condition followed by the completion of two mood and craving questionnaires. They will finally be asked to complete a task that measures the amount of attention they pay to chocolate. Statistical analyses will be conducted to determine the effect of either exercising or not on addictive behaviors to chocolate.

02

Conditions studied

  • Acute Exercise and Addictive Behavior

Browse trials for

03

In context

Behavior, Addictive

521 studies on the registry are indexed under Behavior, Addictive; 124 are open to participants now.

This study's enrollment of 12 is below the median of 62 across 399 interventional studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

University of Miami is the lead sponsor of 840 studies on the registry; 164 are open to participants now.

Of its 115 completed or terminated interventional studies of FDA-regulated products, 97 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • equal or greater than 25
  • Eat at least 3.5 oz of chocolate per day
  • Scorer at least 33 out of a possible 36 on the Handedness Questionnaire
  • Ability to provide
  • No medical to exercise
  • Premenopausal

Exclusion criteria

Exclusion Criteria:

  • PMS
  • Pregnancy
  • Prisoners
  • Risk factors for heart disease as determined by physician
  • Medication that interferes with capacity to exercise
  • Answer "Yes" to PAR-Q
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Exercise

    They will do a 26-min bout of high intensity interval exercise.

    Behavioral: Exercise

  • No intervention
    No exercise

    They will sit quietly for 26 minutes without access to electronic devices or reading materials.

Interventions

  • BehavioralExercise

    Exercise will be performed on a stationary bicycle ergometer.

06

What researchers measure

Primary outcomes

  1. Attentional Bias (AB) to chocolate using a modified visual dot probe task (Kemps et al, 2009)

    AB will be measured using a modified visual dot probe task, which consists of measuring reaction times to neutral images versus chocolate images (Kemps et al, 2009). Neutral images will consist of non-chocolate related items (i.e. office supplies). After 5 practice trials, 60 critical trials will be displayed which consist of either chocolate or neutral images (presented side by side). A black fixation cross will appear behind one of the images, and the subject has to respond as quickly as possible to which image the cross is located behind. The faster the subject responds to the cross behind the chocolate image, the higher their attentional bias is to chocolate. AB will be measured on both days following both the exercise and control conditions.

    Time frame: 15 minutes

Secondary outcomes

  1. Affective Valence measured by The Feeling Scale (Hardy & Rejeski, 1989)

    The Feeling Scale measures affective valence using an 11 point range from -5 to +5 with higher values indicating more pleasure. It is administered on both days following both the exercise and the control condition.

    Time frame: 1 minute

  2. Affective Activation measured by the Felt Arousal Scale (Svebak & Murgatroyd, 1985)

    The Felt Arousal Scale measures affective activation using a 6 point range from 1 to 6 with the higher values indicating greater activation and arousal. It is administered on both days following both the exercise and the control condition.

    Time frame: 1 minute

  3. Cravings for chocolate using the State Food Cravings Questionnaire (Cepeda-Benito et al, 2000)

    This questionnaire measures the acute intensity of chocolate cravings using 15 items with 3 items per dimension. The five state dimensions of food cravings are: an intense desire to consume food, anticipation of positive reinforcement from eating, anticipation of relief from negative states and feelings as a result of eating, lack of control over eating if food is eaten, and craving as a hunger/physiological state. The dimensions will be evaluated using a 5 point Likert scale with the higher score meaning more intense cravings for chocolate. The questionnaire will be administered on both days following both the exercise and the control condition.

    Time frame: 5 minutes

07

Study locations

1 site
  • Laboratory of Clinical and Applied Physiology
    Coral Gables, Florida 33146, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03356509
Responsible party
Arlette Perry (Professor, University of Miami) — Principal investigator
First posted
Nov 29, 2017
Start date
Jan 8, 2018
Primary completion
Sep 15, 2018
Completion
Sep 15, 2018
Last update
Sep 18, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion